Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer
Crossref DOI link: https://doi.org/10.1007/s00280-017-3379-5
Published Online: 2017-07-04
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mbatchi, Litaty C.
Gassiot, Matthieu
Pourquier, Philippe
Goberna, Alejando
Mahammedi, Hakim
Mourey, Loic
Joly, Florence
Lumbroso, Serge
Evrard, Alexandre
Houede, Nadine
License valid from 2017-07-04